repetitive transcranial magnetic stimulation
ProcedureOther names: rTMS
NCT Number: NCT01850836
To investigate the therapeutic effect of dual hemisphere repetitive transcranial magnetic stimulation (rTMS) on post-stroke non fluent aphasia.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Thirty patients with subacute post-stroke non-fluent aphasia were randomly allocated with a ratio 2:1 to receive real (n = 20) or sham (n = 10) rTMS of the affected motor cortex. Each patient received 1000 rTMS pulses (1 Hertz at 110% of resting motor threshold) over the unaffected Broca's area and 1000 pulses (20 Hertz at 100% resting motor threshold) over affected left Broca's area for 10 consecutive days. LANGUAGE section of hemispheric stroke scale, Stroke Aphasic Depression Questionnaire Hospital Version (SADQ-H) and NIH stroke scale were assessed before, post sessions, 1 and 2 months after the last session . Motor threshold was assessed before and after the end of last session.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: rTMS
Time frame: Change from Baseline in HSS at 2 months
Language assessment using hemispheric stroke scale (HSS)
Time frame: Change from Baseline in NIHSS at 2 months
Time frame: Change from Baseline in SADQ-H at 2 months
(Asking about presence of depressive symptoms within last week of stroke to be present all the days or frequent from 4-6 days, or infrequent from 1-4 days, or not at all).
Assiut University
Other
Treatment of Aphasic Stroke Patients With rTMS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01927302
Agrammatism, Agraphia
Chicago, Illinois, United States
View Trial DetailsNCT06891638
Aphasia, Brain Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT05570578
Aphasia, Brain Diseases
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT01540383
Aphasia, Behavior
Münster, North Rhine-Westfalia, Germany
View Trial Details